Other
Moderna and Merck mRNA Cancer Vaccine Curbs Melanoma in Trial
US pharmaceutical firms Merck and Moderna have announced that their personalized mRNA-based therapy, intismeran autogene, successfully reduced tumor recurrence in melanoma patients during a…
